AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Blue-blocking Glasses for Sleep Disorders in Child and Adolescent Psychiatry

RecruitingNAAges 12 Years - 18 YearsAllHelse Fonna
💬

In plain words

What the trial is, and whether it could suit you

Sleep problems and regulation difficulties are frequent in the child and adolescent psychiatry population. Insomnia and delayed sleep-wake phase disorders (DSPWD) are highly prevalent, and risk factors for developing more severe illness courses and chronic disorders. Pharmacological treatments of sleep disorders dominate even for the youngest patients but are unsupported by long-term data on outcome and side effects. The majority of non-pharmacological treatment options are composite and resource demanding. The investigators will examine the effects and feasibility of the isolated intervention of evening/night use of blue-blocking glasses/real darkness as adjunctive treatment for insomnia and delayed sleep phase disorder in inpatient and outpatient settings for children and adolecents.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Age 12-18 years, receiving health-care from child and adolescent mental health services at UPA University Hospital of North Norway, Tromsø or BUP Haugesund Hospital, Haugesund * Current Insomnia or DSPD comorbid to one or several pychiatric symptom presentations or diagnoses * Able and willing to provide written informed consent * Participants aged 12-15,9 years also need consent from both parents/carers * Able to comply with protocol * Able to discontinue melatonin or BB-glasses if currently used, with at least 3 days washout period Exclusion Criteria: * Not able to comply with protocol for a required minimum of one night * Blindness or severely reduced translucency of both eyes * Known malformation or damage of optical tract blindness * Use of melatonin all formulas that cannot be paused * High risk for suicide or self-harm * Consent from both partents/carers unlikely (participants age 12-15,9 years)
💊

What it tests

  • Blue-blocking glasses (BB-glasses) or real darkness from 9 p.m. to desired wake-up time + night mode setting on mobile phone
  • Control
📍

Where

2 sites
BUP Haugesund
Haugesund, Norway
BUPA Tromsø, The University Hospital of North Norway
Tromsø, Norway
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy